{"id":"https://openalex.org/W4411289622","doi":"https://doi.org/10.1158/1557-3265.sabcs24-rf1-02","title":"Abstract RF1-02: Palbociclib plus letrozole versus weekly paclitaxel, both in combination w/ trastuzumab plus pertuzumab, as neoadjuvant treatment for patients w/ HR+/HER2+ early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17)","display_name":"Abstract RF1-02: Palbociclib plus letrozole versus weekly paclitaxel, both in combination w/ trastuzumab plus pertuzumab, as neoadjuvant treatment for patients w/ HR+/HER2+ early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17)","publication_year":2025,"publication_date":"2025-06-13","ids":{"openalex":"https://openalex.org/W4411289622","doi":"https://doi.org/10.1158/1557-3265.sabcs24-rf1-02"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.sabcs24-rf1-02","doi":"https://doi.org/10.1158/1557-3265.sabcs24-rf1-02","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-rf1-02","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089361418","display_name":"Luca Malorni","orcid":"https://orcid.org/0000-0002-4297-2997","observed_orcids":["https://orcid.org/0000-0002-4297-2997"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luca Malorni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010499534","display_name":"Svitlana Tyekucheva","orcid":"https://orcid.org/0000-0002-3119-6507","observed_orcids":["https://orcid.org/0000-0002-3119-6507"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Tyekucheva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021445195","display_name":"Claudio Zamagni","orcid":"https://orcid.org/0000-0002-7143-9091","observed_orcids":["https://orcid.org/0000-0002-7143-9091"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Zamagni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035838287","display_name":"Ursula Hasler-Strub","orcid":"https://orcid.org/0000-0002-2500-5882","observed_orcids":["https://orcid.org/0000-0002-2500-5882"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"U. Hasler-Strub","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073796630","display_name":"Andrea Gombos","orcid":"https://orcid.org/0000-0003-1664-2369","observed_orcids":["https://orcid.org/0000-0003-1664-2369"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Gombos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048961826","display_name":"Camille Chakiba","orcid":"https://orcid.org/0000-0002-6383-9589","observed_orcids":["https://orcid.org/0000-0002-6383-9589"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Chakiba-Brug\u00e8re","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053376791","display_name":"Marco Angelo Colleoni","orcid":"https://orcid.org/0000-0002-5743-3013","observed_orcids":["https://orcid.org/0000-0002-5743-3013","https://orcid.org/0000-0003-1925-2139"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Colleoni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046190895","display_name":"Andreas Mueller","orcid":"https://orcid.org/0000-0003-4561-2628","observed_orcids":["https://orcid.org/0000-0003-4561-2628"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Mueller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089938826","display_name":"Alessandro Marco Minisini","orcid":"https://orcid.org/0000-0001-7712-7286","observed_orcids":["https://orcid.org/0000-0001-7712-7286"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A.M. Minisini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"D. Taylor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Taylor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077858358","display_name":"Jean-Paul Salmon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J.P. Salmon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011883364","display_name":"Elisa Gallerani","orcid":"https://orcid.org/0000-0003-4051-0315","observed_orcids":["https://orcid.org/0000-0003-4051-0315"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Gallerani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084916075","display_name":"Anna Cariello","orcid":"https://orcid.org/0000-0002-2579-6661","observed_orcids":["https://orcid.org/0000-0002-2579-6661"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Cariello","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"A. Fontana","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Fontana","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019129337","display_name":"Heidi Roschitzki\u2010Voser","orcid":"https://orcid.org/0000-0002-5432-2385","observed_orcids":["https://orcid.org/0000-0002-5432-2385"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Roschitzki-Voser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050653783","display_name":"Roswitha Kammler","orcid":"https://orcid.org/0000-0002-5572-7894","observed_orcids":["https://orcid.org/0000-0002-5572-7894"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Kammler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025581681","display_name":"Barbara Ruepp","orcid":"https://orcid.org/0000-0002-1817-643X","observed_orcids":["https://orcid.org/0000-0002-1817-643X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Ruepp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102802705","display_name":"Shrushma Loi","orcid":"https://orcid.org/0000-0002-3815-2320","observed_orcids":["https://orcid.org/0000-0002-3815-2320"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Loi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088697304","display_name":"Giuseppe Viale","orcid":"https://orcid.org/0000-0003-1882-7068","observed_orcids":["https://orcid.org/0000-0003-1882-7068"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Viale","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017334876","display_name":"Meredith M. Regan","orcid":"https://orcid.org/0000-0002-2428-6109","observed_orcids":["https://orcid.org/0000-0002-2428-6109"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.M. Regan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005973748","display_name":"Etienne G.C. Brain","orcid":"https://orcid.org/0000-0003-0881-9371","observed_orcids":["https://orcid.org/0000-0003-0881-9371"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Brain","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5050421775","display_name":"Laura Biganzoli","orcid":"https://orcid.org/0000-0001-7989-8658","observed_orcids":["https://orcid.org/0000-0001-7989-8658"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Biganzoli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"12_Supplement","first_page":"RF1","last_page":"02"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9585000276565552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9585000276565552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.039799999445676804,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hr-her2-breast-cancer","display_name":"hormone receptor-positive HER2-negative breast cancer","score":0.9539999961853027},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.9160000085830688},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/letrozole","display_name":"letrozole","score":0.9909999966621399},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.8999999761581421},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9599999785423279},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":1.0},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/chemotherapy-de-escalation","display_name":"chemotherapy de-escalation","score":0.8679999709129333},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.8610000014305115},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.6470000147819519}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.9012585878372192},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.885168731212616},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.8693050146102905},{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.8686712980270386},{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.7317438721656799},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.5980295538902283},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5365574359893799},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4588634669780731},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4569537937641144},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36084461212158203},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.2985239028930664},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.11921504139900208}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.sabcs24-rf1-02","doi":"https://doi.org/10.1158/1557-3265.sabcs24-rf1-02","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-rf1-02","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415269312","https://openalex.org/W3129775033","https://openalex.org/W2978164091","https://openalex.org/W4313640817","https://openalex.org/W4221122546","https://openalex.org/W4411290277","https://openalex.org/W4255948710","https://openalex.org/W4401332641","https://openalex.org/W2622670954","https://openalex.org/W7129200687"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"HR+/HER2+":[2,68,546,627],"breast":[3,629],"cancer":[4],"(BC)":[5],"is":[6,51],"a":[7,154,304,316,509],"biologically":[8],"heterogeneous":[9],"group":[10],"characterized":[11],"by":[12,219],"low":[13,180,430],"pathological":[14],"complete":[15],"response":[16],"(pCR)":[17],"to":[18,72,255,519,555],"chemotherapy":[19,40],"combined":[20,43,504],"with":[21,44,62,170,178,198,283,292,297,315,505,545,559],"anti-HER2":[22,47,507],"therapy":[23],"and":[24,46,125,134,140,161,175,230,339,367,422,442,482],"relative":[25],"endocrine":[26,45],"resistance":[27],"in":[28,173,181,263,267,270,349,358,382,390,397,413,426,439,450,465,471,479,485,615],"the":[29,151,199,242,352,490,499,528,634,646],"neoadjuvant":[30,622],"setting.":[31],"CDK4/6":[32],"inhibitors":[33],"(CDK4/6i)":[34],"have":[35],"recently":[36],"shown":[37],"potential":[38,557],"for":[39,58,82,92,100,168,176,235,498,542,624],"de-escalation":[41],"when":[42,503],"therapy.":[48],"Methods:":[49],"TOUCH":[50,496,638],"an":[52,539],"international,":[53],"open-label,":[54],"phase":[55,636],"II":[56,192,637],"trial":[57,639],"post-menopausal":[59],"patients":[60,625],"(pts)":[61],"cT>1":[63],"cm,":[64],"cN0":[65,144,314],"or":[66,87],"cN1,":[67],"BC,":[69,547],"randomized":[70,261,635],"1:1":[71],"Paclitaxel":[73],"(T)":[74],"80":[75],"mg/m2":[76],"iv":[77,114],"on":[78],"day":[79],"1,8,15":[80],"q28d":[81],"4":[83,93,274],"cycles":[84,94,108,343],"(arm":[85,103],"A)":[86],"Palbociclib":[88,608],"(Pal)":[89],"standard":[90,116],"dose/schedule":[91],"plus":[95,609,619],"Letrozole":[96],"(L)":[97],"2.5":[98],"mg/day":[99],"16":[101],"weeks":[102],"B).":[104,487],"All":[105],"received":[106],"5":[107,342],"of":[109,156,289,319,344,351,407,469,513,524,527,531,533,645],"trastuzumab":[110,618],"sc":[111],"+":[112,204],"pertuzumab":[113],"(HP)":[115],"dose":[117,406],"q3w.":[118],"Randomization":[119],"was":[120,150,184,217,239,246,278,347,378,394,411,417,431,457,493],"stratified":[121],"by:":[122],"a)":[123],"age":[124,277,290],"G8":[126,135,141,293,298],"geriatric":[127],"score":[128,216,294],"(<65":[129],"y":[130,133,139],"vs":[131,137,145,334,337,361,364,385,429,435,446,467,474],"\u226565":[132,138],">14":[136],"\u226414);":[142,299],"b)":[143],"cN1.":[146],"The":[147,522],"primary":[148,491,631],"objective":[149],"interaction":[152,245,419],"between":[153,374,420],"gene-signature":[155],"E2F":[157],"pathway":[158],"activity":[159],"(RBsig)":[160],"pCR":[162,167,366,377,421,425,516],"(ypT0/ypTis":[163],"ypN0),":[164],"hypothesizing":[165],"higher":[166],"tumors":[169,177],"RBsig":[171,179,393,410,423,427],"high":[172,428],"T+HP,":[174],"Pal+L+HP.":[182],"RNA-sequencing":[183],"performed":[185,348],"from":[186,273,633],"pre-treatment":[187],"FFPE":[188],"biopsies":[189],"(NEBNext\u00ae":[190],"UltraTM":[191],"Directional":[193],"RNA":[194],"Library":[195],"Prep":[196],"Kit":[197],"Twist":[200],"Human":[201],"Core":[202],"Exome":[203],"Custom":[205],"IntegraGen":[206],"Enrichment":[207],"V2":[208],"capture":[209],"System,":[210],"Paired":[211],"End":[212],"100b":[213],"reads).":[214],"RBSig":[215],"calculated":[218],"first":[220,500],"standardizing":[221],"each":[222,236],"normalized":[223],"gene":[224],"measurement":[225],"across":[226],"all":[227],"sequenced":[228],"specimens":[229],"adding":[231],"up":[232],"standardized":[233],"values":[234],"gene.":[237],"RbSig":[238],"dichotomized":[240],"at":[241,308,402],"median.":[243],"Treatment-by-RBSig":[244],"estimated":[247],"using":[248],"logistic":[249],"regression.":[250],"Results:":[251],"From":[252],"October":[253],"2018":[254],"July":[256],"2022,":[257],"145":[258],"pts":[259,285,301,311,325,331,399,470,544],"were":[260,313,372,463],"(73":[262],"arm":[264,268,359,383,391,414,472],"A,":[265,441],"72":[266],"B)":[269],"37":[271],"centers":[272],"countries.":[275],"Median":[276,409],"69":[279],"years":[280],"(IQR":[281,322],"63,73),":[282],"99":[284],"(68%)":[286],"being":[287,355],"\u226565y":[288],"(65":[291],">14,":[295],"34":[296],"132":[300],"(91%)":[302],"had":[303,327],"ECOG":[305],"PS":[306],"0;":[307],"diagnosis":[309],"109":[310],"(75%)":[312],"median":[317],"cT":[318],"30":[320],"mm":[321],"20-40);":[323],"76":[324],"(56%)":[326],"G3":[328],"tumors.":[329],"More":[330],"completed":[332,341,401],"Pal":[333],"T":[335],"(94.4%":[336],"79.5%)":[338],">95%":[340],"HP.":[345],"Surgery":[346],"98.6%":[350],"pts,":[353],"BCS":[354],"more":[356],"frequent":[357],"B":[360,476],"A":[362,384,473,481],"(82%":[363],"67%).":[365],"other":[368],"secondary":[369],"efficacy":[370],"endpoints":[371],"similar":[373,518],"arms.":[375],"Overall,":[376],"32.9%":[379],"(95%CI:":[380,433,437,444,448],"22.3-44.9)":[381],"33.3%":[386],"(95%":[387],"CI:":[388],"25.5-41.4)":[389],"B.":[392,415,452,596],"successfully":[395],"determined":[396],"115":[398],"who":[400],"least":[403],"one":[404],"full":[405],"treatment.":[408],"lower":[412],"There":[416],"no":[418],"(p=0.18):":[424],"31%":[432],"16.1-50)":[434],"42%":[436],"23.3-63.1)":[438],"Arm":[440,451,475,480,486],"38%":[443],"20.2-59.4)":[445],"26%":[447],"11.9-44.6)":[449],"No":[453],"new":[454],"safety":[455],"signal":[456],"observed.":[458],"Grade":[459],"3-4":[460],"adverse":[461],"events":[462],"seen":[464],"31.5%":[466],"54.1%":[468],"(mainly":[477],"diarrhea":[478],"asymptomatic":[483],"neutropenia":[484,532],"Conclusions:":[488],"Although":[489],"hypothesis":[492],"not":[494],"supported,":[495],"shows":[497],"time":[501],"that,":[502],"dual":[506],"blockade,":[508],"de-escalated":[510],"chemo-free":[511],"backbone":[512],"Pal+L":[514,534],"yields":[515],"rates":[517],"weekly":[520,612],"T.":[521],"lack":[523],"clinical":[525],"impact":[526],"increased":[529],"rate":[530],"suggests":[535],"it":[536],"might":[537],"represent":[538],"attractive":[540],"alternative":[541],"postmenopausal":[543],"especially":[548],"older":[549],"ones.":[550],"Translational":[551],"studies":[552],"are":[553],"ongoing":[554],"uncover":[556],"gene-signatures":[558],"prognostic/predictive":[560],"significance.":[561],"Citation":[562],"Format:":[563],"Luca":[564],"Malorni,":[565],"S.":[566,598],"Tyekucheva,":[567],"C.":[568,574],"Zamagni,":[569],"U.":[570],"Hasler-Strub,":[571],"A.":[572,578,588,590],"Gombos,":[573],"Chakiba-Brug\u00e8re,":[575],"M.":[576],"Colleoni,":[577],"Mueller,":[579],"A.M.":[580],"Minisini,":[581],"D.":[582],"Taylor,":[583],"J.P.":[584],"Salmon,":[585],"E.":[586,604],"Gallerani,":[587],"Cariello,":[589],"Fontana,":[591],"H.":[592],"Roschitzki-Voser,":[593],"R.":[594],"Kammler,":[595],"Ruepp,":[597],"Loi,":[599],"G.":[600],"Viale,":[601],"M.M.":[602],"Regan,":[603],"Brain,":[605],"L.":[606],"Biganzoli.":[607],"letrozole":[610],"versus":[611],"paclitaxel,":[613],"both":[614],"combination":[616],"w/":[617,626],"pertuzumab,":[620],"as":[621],"treatment":[623],"early":[628],"cancer:":[630],"results":[632],"(IBCSG":[640],"55-17)":[641],"[abstract].":[642],"In:":[643],"Proceedings":[644],"San":[647,656],"Antonio":[648],"Breast":[649],"Cancer":[650,663],"Symposium":[651],"2024;":[652],"2024":[653],"Dec":[654],"10-13;":[655],"Antonio,":[657],"TX.":[658],"Philadelphia":[659],"(PA):":[660],"AACR;":[661],"Clin":[662],"Res":[664],"2025;31(12":[665],"Suppl):Abstract":[666],"nr":[667],"RF1-02.":[668]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}